Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (787)

2024

  1. Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: Focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degeneration

    Pharmacological Research, Vol. 205

  2. Aptamer functionalization effect on the interaction of sphingomyelin nanoemulsions with plasma proteins. A thermodynamic approach

    Journal of Molecular Liquids, Vol. 397

  3. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

    International Journal of Pharmaceutics, Vol. 652

  4. Corrigendum to "Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients"

    Molecular & cellular proteomics : MCP

  5. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans

    Journal of Endocrinological Investigation, Vol. 47, Núm. 5, pp. 1139-1154

  6. Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue

    Biochemical Pharmacology, Vol. 223

  7. Implantable SDF-1α-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: Between chemoattraction and tumor shaping into resection cavities

    Acta Biomaterialia, Vol. 173, pp. 261-282

  8. Modulation of Abundance and Location of High-Mobility Group Box 1 in Human Microglia and Macrophages under Oxygen-Glucose Deprivation

    ACS Pharmacology and Translational Science, Vol. 7, Núm. 3, pp. 680-692

  9. Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia

    Genes and Diseases, Vol. 11, Núm. 3

  10. New Perspectives in Neuroprotection for Ischemic Stroke

    Neuroscience

  11. Partial volume correction in longitudinal tau PET studies: is it really needed?

    NeuroImage, Vol. 289

  12. Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab

    Pharmaceuticals, Vol. 17, Núm. 2

  13. The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration

    Pharmaceutics, Vol. 16, Núm. 1

  14. Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke

    Journal of Nanobiotechnology, Vol. 22, Núm. 1

  15. Towards Precision Medicine in Clinical Practice: Alinity C vs. UHPLC-MS/MS in Plasma Aripiprazole Determination

    Pharmaceutics, Vol. 16, Núm. 1

  16. Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling

    Psychiatry Research, Vol. 333

  17. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. A Biomathematical Model of Tumor Response to Radioimmunotherapy with αpDL1 and αcTLA4

    IEEE/ACM Transactions on Computational Biology and Bioinformatics, Vol. 20, Núm. 2, pp. 808-821

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy

    Pharmaceutics, Vol. 15, Núm. 8